Study to Investigate Outcome of Individualized Treatment in Patients With Metastatic Colorectal Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Metastatic Colorectal Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Oslo University Hospital, Oslo, Norway
Contact: Study coordinator (Tormod K Guren, MDPhD)

Study leads

Tormod K Guren, MDPhD
Principal Investigator
Oslo University Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

Pancreatic Ductal Adenocarcinoma · Non Small Cell Lung Cancer · Colorectal Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Los Angeles, United States · Baltimore, United States

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

Advanced/Metastatic Solid Tumors · Colorectal Cancer · Gastric Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

La Jolla, United States · Los Angeles, United States

A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer

Metastatic Colorectal Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

New Haven, United States · Grand Rapids, United States

Phase II Study of Anti-PD-1/VEGF Bispecific Antibody Ivonescimab in Patients With Previously Treated Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

Abroad (travel likely)RecruitingPHASE2

Houston, United States